Nanobodies: Natural Single-Domain Antibodies

被引:1419
|
作者
Muyldermans, Serge [1 ,2 ]
机构
[1] Vrije Univ Brussel, Res Grp Cellular & Mol Immunol, B-1050 Brussels, Belgium
[2] Vrije Univ Brussel VIB, Dept Biol Struct, B-1050 Brussels, Belgium
来源
关键词
camel; llama; shark; heavy-chain antibody; VHH; single-domain antibody; HEAVY-CHAIN ANTIBODIES; CRYSTAL-STRUCTURE; ANTIGEN-BINDING; DISULFIDE BOND; IN-VIVO; AFFINITY MATURATION; ONLY ANTIBODIES; LOOP STRUCTURES; PHAGE DISPLAY; VHH-FRAGMENTS;
D O I
10.1146/annurev-biochem-063011-092449
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sera of camelids contain both conventional heterotetrameric antibodies and unique functional heavy (H)-chain antibodies (HCAbs). The H chain of these homodimeric antibodies consists of one antigen-binding domain, the VHH, and two constant domains. HCAbs fail to incorporate light (L) chains owing to the deletion of the first constant domain and a reshaped surface at the VHH side, which normally associates with L chains in conventional antibodies. The genetic elements composing HCAb shave been identified, but the in vivo generation of these antibodies from their dedicated genes into antigen-specific and affinity-matured bona fide antibodies remains largely underinvestigated. However, the facile identification of antigen-specific VHHs and their beneficial biochemical and economic properties (size, affinity, specificity, stability, production cost) supported by multiple crystal structures have encouraged antibody engineering of these single-domain antibodies for use as a research tool and in biotechnology and medicine.
引用
收藏
页码:775 / 797
页数:23
相关论文
共 50 条
  • [1] Application of Single-Domain Antibodies ("Nanobodies") to Laboratory Diagnosis
    Pillay, Tahir S.
    Muyldermans, Serge
    [J]. ANNALS OF LABORATORY MEDICINE, 2021, 41 (06) : 549 - 558
  • [2] Single-Domain Antibodies or Nanobodies: A Class of Next-Generation Antibodies
    Khodabakhsh, Farnaz
    Behdani, Mahdi
    Rami, Abbas
    Kazemi-Lomedasht, Fatemeh
    [J]. INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2018, 37 (06) : 316 - 322
  • [3] Targeted Alpha Therapy (TAT) with Single-Domain Antibodies (Nanobodies)
    Hurley, Kate
    Cao, Meiyun
    Huang, Haiming
    Wang, Yi
    [J]. CANCERS, 2023, 15 (13)
  • [4] The role of single-domain antibodies (or nanobodies) in SARS-CoV-2 neutralization
    Zebardast, Arghavan
    Hosseini, Parastoo
    Hasanzadeh, Ali
    Latifi, Tayebeh
    [J]. MOLECULAR BIOLOGY REPORTS, 2022, 49 (01) : 647 - 656
  • [5] The role of single-domain antibodies (or nanobodies) in SARS-CoV-2 neutralization
    Arghavan Zebardast
    Parastoo Hosseini
    Ali Hasanzadeh
    Tayebeh latifi
    [J]. Molecular Biology Reports, 2022, 49 : 647 - 656
  • [6] Immunogenicity and humanization of single-domain antibodies
    Rossotti, Martin A.
    Belanger, Kasandra
    Henry, Kevin A.
    Tanha, Jamshid
    [J]. FEBS JOURNAL, 2022, 289 (14) : 4304 - 4327
  • [7] Single-domain antibodies make a difference
    Saelens, Xavier
    Schepens, Bert
    [J]. SCIENCE, 2021, 371 (6530) : 681 - 682
  • [8] Single-Domain Antibodies for Brain Targeting
    Lalatsa, Aikaterini
    Leite, Diana M.
    [J]. BIOPHARM INTERNATIONAL, 2014, 27 (08) : 20 - 26
  • [9] Single-domain antibodies for biomedical applications
    Krah, Simon
    Schroeter, Christian
    Zielonka, Stefan
    Empting, Martin
    Valldorf, Bernhard
    Kolmar, Harald
    [J]. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2016, 38 (01) : 21 - 28
  • [10] Characterization of Novel Single-Domain Nanobodies Against NEIL1
    Thompson, Marlo K.
    Sharma, Nidhi
    Arrington, Jennifer F.
    Andrews, Joel F.
    Prakash, Aishwarya
    [J]. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2022, 63 : 108 - 108